Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
BMJ Open|August 15, 2020
Protocol for systematic review and meta-analysis: impact of statins as immune-modulatory agents on inflammatory markers in adults with chronic diseasesSolima Sabeel, Bongani Motaung, Mumin Ozturk, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Evaluation of minor groove binders (MGBs) as novel anti-mycobacterial agents and the effect of using non-ionic surfactant vesicles as a delivery system to improve their efficacyLerato Hlaka, Michael-Jon Rosslee, Mumin Ozturk, et al.
Frontiers in Immunology|April 4, 2019
Differential Targeting of c-Maf, Bach-1, and Elmo-1 by microRNA-143 and microRNA-365 Promotes the Intracellular Growth of Mycobacterium tuberculosis in Alternatively IL-4/IL-13 Activated MacrophagesOusman Tamgue, Lorna Gcanga, Mumin Ozturk, et al.
Diseases (Basel, Switzerland)|February 26, 2026
Host Serum Biomarker Signatures in Mycobacteriologically Cured Pulmonary Tuberculosis Patients with Persistent Lung Inflammation on 18F-FDG PET/CTBongani Motaung, Solima Sabeel, Mumin Ozturk, et al.
Nucleic Acid Therapeutics|July 27, 2022
Host-Directed Targeting of LincRNA-MIR99AHG Suppresses Intracellular Growth of Mycobacterium tuberculosisLorna Gcanga, Ousman Tamgue, Mumin Ozturk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 7, 2026
IFITM1 differentially regulates antibacterial immunity and immunopathology but is dispensable for antiparasitic responsesSibongiseni K L Poswayo, Mumin Ozturk, Rudranil Hazra, et al.
The British Journal of Nutrition|April 5, 2021
n-3 long-chain PUFA promote antibacterial and inflammation-resolving effects in Mycobacterium tuberculosis-infected C3HeB/FeJ mice, dependent on fatty acid statusArista Nienaber, Mumin Ozturk, Robin Dolman, et al.
The Journal of Infectious Diseases|November 5, 2021
IL-4i1 Regulation of Immune Protection During Mycobacterium tuberculosis InfectionLerato Hlaka, Mumin Ozturk, Julius E Chia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 10, 2015
Batf2/Irf1 induces inflammatory responses in classically activated macrophages, lipopolysaccharides, and mycobacterial infectionSugata Roy, Reto Guler, Suraj P Parihar, et al.
The Journal of Antimicrobial Chemotherapy|January 27, 2022
Intranasally administered S-MGB-364 displays antitubercular activity and modulates the host immune response to Mycobacterium tuberculosis infectionNathan S Kieswetter, Mumin Ozturk, Lerato Hlaka, et al.
Pageof 4